<?xml version="1.0" encoding="UTF-8"?>
<fig id="vaccines-07-00046-f002" orientation="portrait" position="float">
 <label>Figure 2</label>
 <caption>
  <p>Immunostimulation of neutralizing antibodies against H1N1pdm2009 and MERS-CoV in mice. (
   <bold>a</bold>) Experimental timeline. (
   <bold>b</bold>) Hemagglutinin Inhibition (HAI) antibody titers against rgH1N1pdm09 in mice sera of vaccinated groups with OMVs-H1/RBD and inactivated H1N1pdm09 were monitored every two weeks in comparison to control PBS and OMVs-empty groups. Statistical changes marked by * 
   <italic>p</italic> value &lt; 0.05, ** 
   <italic>p</italic> value &lt; 0.01, *** 
   <italic>p</italic> value &lt; 0.001 and ns 
   <italic>p</italic> value &gt; 0.05 non-significant change. (
   <bold>c</bold>) Neutralization titer against MERS-CoV for mice sera vaccinated with inactivated MERS-CoV and OMVs-H1/RBD using plaque reduction neutralization (PRNT) assay. Statistical changes marked by * 
   <italic>p</italic> value &lt; 0.05, ** 
   <italic>p</italic> value &lt; 0.01, *** 
   <italic>p</italic> value &lt; 0.001 and ns 
   <italic>p</italic> value &gt; 0.05 non-significant change.
  </p>
 </caption>
 <graphic xlink:href="vaccines-07-00046-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
